Dirk Hasenclever
AuthID: R-00G-R0H
1
TITLE: Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)
AUTHORS: Anne Catherine Pouleur; Stefan Anker; Dulce Brito; Oana Brosteanu; Dirk Hasenclever; Barbara Casadei; Frank Edelmann; Gerasimos Filippatos; Damien Gruson; Ignatios Ikonomidis; Renaud Lhommel; Masliza Mahmod; Stefan Neubauer; Alexandre Persu; Bernhard L Gerber; Stefan Piechnik; Burkert Pieske; Elisabeth Pieske Kraigher; Fausto Pinto; Piotr Ponikowski; ...More
PUBLISHED: 2018, SOURCE: ESC HEART FAILURE, VOLUME: 5, ISSUE: 5
AUTHORS: Anne Catherine Pouleur; Stefan Anker; Dulce Brito; Oana Brosteanu; Dirk Hasenclever; Barbara Casadei; Frank Edelmann; Gerasimos Filippatos; Damien Gruson; Ignatios Ikonomidis; Renaud Lhommel; Masliza Mahmod; Stefan Neubauer; Alexandre Persu; Bernhard L Gerber; Stefan Piechnik; Burkert Pieske; Elisabeth Pieske Kraigher; Fausto Pinto; Piotr Ponikowski; ...More
PUBLISHED: 2018, SOURCE: ESC HEART FAILURE, VOLUME: 5, ISSUE: 5
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Association of MICA with rheumatoid arthritis independent of known HLA-DRB1 risk alleles in a family-based and a case control study
AUTHORS: Holger Kirsten; Elisabeth Petit Teixeira; Markus Scholz; Dirk Hasenclever; Helene Hantmann; Dirk Heider; Ulf Wagner; Ulrich Sack; Vitor Hugo Teixeira; Bernard Prum; Jana Burkhardt; Celine Pierlot; Frank Emmrich; Francois Cornelis; Peter Ahnert;
PUBLISHED: 2009, SOURCE: ARTHRITIS RESEARCH & THERAPY, VOLUME: 11, ISSUE: 3
AUTHORS: Holger Kirsten; Elisabeth Petit Teixeira; Markus Scholz; Dirk Hasenclever; Helene Hantmann; Dirk Heider; Ulf Wagner; Ulrich Sack; Vitor Hugo Teixeira; Bernard Prum; Jana Burkhardt; Celine Pierlot; Frank Emmrich; Francois Cornelis; Peter Ahnert;
PUBLISHED: 2009, SOURCE: ARTHRITIS RESEARCH & THERAPY, VOLUME: 11, ISSUE: 3
